(Q35106480)

6 August 2017

1 reference

title

Aldosterone as a target in congestive heart failure (English)

1 reference

6 August 2017

1 reference

congestive heart failure

1 reference

2

Bertram Pitt

1 reference

6 August 2017

Sanjay Rajagopalan

1

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12693733

23 December 2023

publication date

1 March 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0025712502001839?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00183-9

https://api.elsevier.com/content/article/PII:S0025712502001839?httpAccept=text/plain

23 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00183-9

Medical Clinics of North America

23 December 2023

published in

1 reference

6 August 2017

87

1 reference

6 August 2017

441-457

1 reference

6 August 2017

2

1 reference

Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Hormones and hemodynamics in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Two-year time course and significance of neurohumoral activation in the Survival and Ventricular Enlargement (SAVE) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Aldosterone antagonists in the treatment of hypertension and target organ damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

"Escape" of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Endothelins stimulate aldosterone secretion from dispersed rat adrenal zona glomerulosa cells, acting through ETB receptors coupled with the phospholipase C-dependent signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

The role of endothelial cell products in the regulation of adrenocortical function: actions of endothelin, nitric oxide, adrenomedullin and PAMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

The role of nitric oxide in the regulation of aldosterone synthesis by adrenal glomerulosa cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Regulation of aldosterone secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Remodeling of the rat right and left ventricles in experimental hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Rapid effects of aldosterone on free intracellular calcium in vascular smooth muscle and endothelial cells: subcellular localization of calcium elevations by single cell imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Nongenomic effects of aldosterone on intracellular Ca2+ in vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Vasodilation to acetylcholine in primary and secondary forms of human hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Mineralocorticoid receptor antagonism in experimental atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

High affinity NAD(+)-dependent 11 beta-hydroxysteroid dehydrogenase in the human heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Aldosterone, salt and cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Epidemiological findings imply that goals for drug treatment of hypertension need to be revised

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Mechanical factors predicting cardiovascular risk and drug treatment of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Association between increased plasma levels of aldosterone and decreased systemic arterial compliance in subjects with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

The role of proteinases in angiogenesis, heart development, restenosis, atherosclerosis, myocardial ischemia, and stroke: insights from genetic studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Aldosterone inhibition limits collagen synthesis and progressive left ventricular enlargement after anterior myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Aldosterone antagonists destabilize the mineralocorticosteroid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2802%2900183-9

Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone

7 January 2021

series ordinal

33

1 reference

https://api.crossref.org/works/10.1016/S0025-7125(02)00183-9

23 December 2023

Identifiers

1 reference

6 August 2017

1 reference